Long-term efficacy and safety of Canakinumab in active Hyper-IgD syndrome (HIDS): results from an open-label study

Mevalonate kinase deficiency

Mevalonate kinase deficiency (MKD), is an autosomal recessive metabolic disorder that disrupts the biosynthesis of cholesterol and isoprenoids.